Table 1.
The involvement of NETs in the development of NAFLD.
| Year | Immune responses | Phenotype | Study model | |
|---|---|---|---|---|
| Innate | Adaptive | |||
| 2018 (32) | Neutrophils infiltration ↑ Macrophage infiltration ↑ |
N/A | • MPO ↑ • H3Cit ↑ • Tumor formation ↑ |
STAM mouse model |
| 2019 (52) | Neutrophils infiltration ↑ | • CD4+ T cells ↓ • CD8+ T cells ↓ • T cell exhaustion ↑ |
• H3Cit-DNA ↑ • Tumor formation ↑ |
STAM mouse model |
| 2020 (53) | Neutrophils infiltration ↑ | N/A | • MPO ↑ • H3Cit ↑ • S1P ↑ • NETosis ↑ • Neutrophil spontaneous apoptosis ↓ • Liver fibrosis ↑ |
MCD-HFD mouse model |
| 2021 (33) | Neutrophils infiltration ↑ Macrophage infiltration ↑ DC ↑ |
• CD4+ T cells ↓ • Treg ↑ • B cells ↑ |
• H3Cit ↑ • OXPHOS ↑ • Tumor formation ↑ |
STAM and WD mouse models |
| 2021 (54) | N/A | N/A | • MPO ↑ • H3Cit ↑ • TAT ↑ |
HCC and cirrhosis patients |
| 2022 (55) | N/A | N/A | • MPO ↑ • H3Cit ↑ • NE ↑ • TAT ↑ |
Liver cirrhosis patients with PVT |
| 2022 (56) | N/A | N/A | • TAT ↑ • CT ↓ • Coagulation ↓ • Thrombin and fibrin formation ↑ |
NASH patients |
| 2022 (57) | N/A | N/A | • MPO ↑ • H3Cit ↑ • NE ↑ • Platelet ↑ • NETs/IL-1β/IL-17A colocalization ↑ |
NASH and hepatitis patients |
| 2023 (58) | Neutrophil infiltration ↑ Macrophage infiltration ↑ |
• CD4+ T cells ↓ • CD8+ T cells ↑ |
• MPO ↑ • H3Cit ↑ • NE ↑ |
MCD-HFD and HFHC-NASH mouse models |
N/A, data not available; MPO-DNA, myeloperoxidase associated DNA; H3Cit-DNA, histone H3 associated DNA; S1P, sphingosine 1-phosphate; MCDHF, methionine/choline deficient diet-high fat diet; DC, dendritic cells; OXPHOS, oxidative phosphorylation; WD, western diet; STAM, stelic animal model, HCC, hepatocellular carcinoma; NE, neutrophil elastase; CT, coagulation time; TAT, thrombin-antithrombin; PVT, portal vein thrombosis; IL-6, interleukin-6; IL-1β, interleukin-1β; HFHC, high fat and high cholesterol diet.